Most read reports
- Crop Prospects and Food Situation, No. 3, September 2018
- A Future Stolen: Young and out of school
- The State of Food Security and Nutrition in the World 2018: Building climate resilience for food security and nutrition [EN/AR/RU]
- ECOWAS calls for increased coordination to address security and developmental challenges in Sahel region
- Levels & Trends in Child Mortality: Report 2018
L'épidémie de maladie à virus Ebola (MVE) qui a sévi en Afrique de l’Ouest en 2014-2015, plus particulièrement en Guinée, au Liberia et en Sierra Leone, a engendré plus de 28 000 cas et fait plus de 11 000 victimes.
The Security Sector’s Role in Responding to Health Crises representatives from key regional organizations involved in the Ebola response, including the African Union (AU) and the Mano River Union (MRU), as well as additional researchers, Ebola Task Force coordinators at national and regional levels, and representatives of the diplomatic and international community based in Freetown. Participants shared practical recommendations to facilitate better preparedness to mitigate future epidemics.
ADAM LUPEL AND MICHAEL SNYDER
The outbreak of the Ebola virus disease in West Africa from 2014 to 2015 underscored the fragility of public health services in countries emerging from protracted conflict, as well as the link between governance and health. In both Sierra Leone and Liberia, war had seriously undermined the health sector. Ebola arrived as the large-scale postwar international presence was downsizing and the responsibility for healthcare was shifting to the governments.
This report documents the secondary humanitarian problems and impacts of large-scale Ebola outbreak on the different humanitarian sectors, to provide a non-exhaustive plan to help future responders. A large scale Ebola outbreak, in this document, refers to an epidemic with an unprecedented scale, geographical spread and duration.
Working and discussion papersMarc DuBois and Caitlin Wake, with Scarlett Sturridge and Christina Bennett
Though often described as unprecedented, the Ebola response reflects long-standing strengths and weaknesses with how aid works. Aid organisations proved dedicated and resourceful but also ill-prepared and insufficiently engaged with local communities.
Although well-used to danger, aid organisations struggled to overcome their fear of the virus and determine how to protect their staff in such an uncertain environment.
14 OCTOBRE 2015 | GENÈVE | FREETOWN | WASHINGTON - Les résultats préliminaires d’une étude sur la persistance du virus Ebola dans les liquides biologiques montrent que certains hommes produisent encore des échantillons de sperme donnant un test positif à la recherche du virus Ebola 9 mois après l’apparition des symptômes.
Preliminary results of a study into persistence of Ebola virus in body fluids show that some men still produce semen samples that test positive for Ebola virus nine months after onset of symptoms.
The report, published today in the New England Journal of Medicine, provides the first results of a long-term study being jointly conducted by the Sierra Leone Ministry of Health and Sanitation, Sierra Leone Ministry of Defence, the World Health Organization and the U.S. Centers for Disease Control and Prevention.
China’s first homegrown vaccine against Ebola has entered its second phase in a clinical trial in Sierra Leone in West Africa, marking a breakthrough in overseas testing of Chinese-developed vaccines. Chen Wei, a researcher at the Institute of Microbiology and Epidemiology of the Academy of Military Medical Sciences, said on Oct 12 that dozens of volunteers recruited from among local people had been given the shots to test the vaccine’s safety and effectiveness.
NEW BRUNSWICK, NEW JERSEY—Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone.
The vaccine regimen is part of a new study being conducted in that nation's Kambia district, where some of the country's most recent Ebola cases have been reported.
More than 11,000 people have died from the Ebola virus since the latest outbreak emerged in late 2013, nearly all of them in West Africa in and around Sierra Leone.
There is currently no licensed vaccine, treatment or cure for Ebola.
What is the Pandemic Emergency Facility?
The World Bank Group (WBG) is working closely with the World Health Organization (WHO) and many other partners to design a global Pandemic Emergency Financing Facility (PEF) so that when the next global health emergency is declared, the world has the financial resources to quickly deploy trained health workers, equipment, medicines and whatever else is required. G-7 and G-20 leaders requested the WBG to accelerate development of the PEF as a means to strengthen the global response to future potential pandemics.
Ebola could be “soundly defeated” by the end of the year if the intensity of case detection and contact tracing was sustained, the Director-General of the World Health Organization (WHO) told the Security Council today, outlining reforms to improve the organization’s performance and crediting unwavering leadership, especially in Liberia, Guinea and Sierra Leone, for a “night-and-day” difference in the situation from less than a year ago.
The Ebola virus disease (EBOLA) outbreak in West Africa has the worst death toll since the disease was diagnosed in 1976. It also has far-reaching socioeconomic consequences.
7 July 2015
The 6th meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the Ebola virus disease (EVD) outbreak in West Africa took place by teleconference on Thursday, 2 July 2015, and by electronic correspondence from 2-6 July 2015.
As in previous meetings, the Committee’s role was to advise the WHO Director-General as to:
whether the event continues to constitute a Public Health Emergency of International Concern (PHEIC) and, if so,
A tablet device that can withstand being doused in chlorine has been developed to help medics caring for patients with Ebola.
Designed by technology volunteers and Google, it can be used even wearing gloves and in storms and high humidity.
Medecins Sans Frontieres put out a call for an Ebola-proof tablet to help teams record vital patient information.
By David Lai, Ebola Crisis Policy and Information Management Coordinator
March 3, 2015
Today a major international donor conference is taking place in Brussels to plan the rebuilding of Ebola hit countries. Having just recently returned from Sierra Leone and Liberia, I would like to share my reflection on how the impact of the crisis is affecting women and girls. Quite a crucial aspect, and a gender transformative approach should inform donor commitment in Brussels this Tuesday.
Summary: 24 February 2015, Brussels - The fight against Ebola has moved one step closer to an effective treatment against the disease. Thanks to EU funding from the Horizon 2020 research and innovation programme, the French National Institute of Health and Medical Research (INSERM) last night announced encouraging evidence that the antiviral drug favipiravir might be an effective treatment against early Ebola disease.
30 janvier 2015 – A l'occasion d'un Sommet de l'Union africaine à Addis-Abeba, en Ethiopie, le Secrétaire général des Nations Unies, Ban Ki-moon, a salué vendredi la solidarité affichée par l'Afrique envers le Libéria, la Guinée et la Sierra Leone, les trois pays les plus affectés par l'épidémie d'Ebola.
Following are UN Secretary-General Ban Ki-moon’s remarks, as prepared for delivery, at the round table on the Ebola outbreak, in Addis Ababa today:
Thank you for organizing this working lunch. This Ebola outbreak is the largest the world has ever known. More than 21,000 people have been infected. Some 8,500 have died. I saw the evidence myself when I visited Guinea, Liberia, Sierra Leone and Mali a few weeks ago. People’s lives and livelihoods have been devastated.